Charles River Laboratories International, Inc. (CRL)
290.19
+3.36
(+1.17%)
USD |
NYSE |
Oct 02, 16:00
291.00
+0.81
(+0.28%)
Pre-Market: 20:00
Charles River Laboratories International Price to Book Value : 4.878 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 4.878 |
| October 01, 2026 | 4.821 |
| September 30, 2026 | 4.958 |
| September 29, 2026 | 4.974 |
| September 28, 2026 | 4.951 |
| September 25, 2026 | 4.922 |
| September 24, 2026 | 4.949 |
| September 23, 2026 | 4.661 |
| September 22, 2026 | 4.792 |
| September 21, 2026 | 4.690 |
| September 18, 2026 | 4.674 |
| September 17, 2026 | 4.734 |
| September 16, 2026 | 4.595 |
| September 15, 2026 | 4.586 |
| September 14, 2026 | 4.590 |
| September 11, 2026 | 4.677 |
| September 10, 2026 | 4.588 |
| September 09, 2026 | 4.678 |
| September 08, 2026 | 4.719 |
| September 04, 2026 | 4.849 |
| September 03, 2026 | 4.931 |
| September 02, 2026 | 4.904 |
| September 01, 2026 | 4.746 |
| August 31, 2026 | 4.845 |
| August 28, 2026 | 4.900 |
| Date | Value |
|---|---|
| August 27, 2026 | 4.982 |
| August 26, 2026 | 4.96 |
| August 25, 2026 | 5.003 |
| August 24, 2026 | 5.018 |
| August 21, 2026 | 4.962 |
| August 20, 2026 | 4.899 |
| August 19, 2026 | 4.874 |
| August 18, 2026 | 4.693 |
| August 17, 2026 | 4.818 |
| August 14, 2026 | 4.707 |
| August 13, 2026 | 4.728 |
| August 12, 2026 | 4.780 |
| August 11, 2026 | 4.740 |
| August 10, 2026 | 4.656 |
| August 07, 2026 | 4.496 |
| August 06, 2026 | 4.463 |
| August 05, 2026 | 4.382 |
| August 04, 2026 | 3.935 |
| August 03, 2026 | 3.880 |
| July 31, 2026 | 3.908 |
| July 30, 2026 | 3.943 |
| July 29, 2026 | 3.946 |
| July 28, 2026 | 4.041 |
| July 27, 2026 | 3.77 |
| July 24, 2026 | 3.808 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| IQVIA Holdings, Inc. | 6.887 |
| Medpace Holdings, Inc. | 38.47 |
| Fortrea Holdings, Inc. | 3.628 |
| Champions Oncology, Inc. | 17.66 |
| Avantor, Inc. | 1.843 |
Price to Book Value Related Metrics
| PS Ratio | 3.549 |
| PEG Ratio | -0.2246 |
| Price to Free Cash Flow | 38.29 |
| Price | 290.19 |
| Earnings Yield | -1.67% |
| Market Cap | 13.85B |
| PEGY Ratio | -0.2246 |
| Operating PE Ratio | 26.26 |
| Normalized PE Ratio | 154.23 |